High Conviction Ideas & Track Record

Muffett's Best Calls

Asymmetric setups, structural megatrend leaders, and high-margin inflection ideas identified through our disciplined internal research process.

+140%
Avg Milestone Gain
84%
Thesis Validation Rate
6-18 mo
Holding Horizon
Stage 2
Breakout Timing
NYSE: CDE +165% Peak

Coeur Mining Inc.

Silver & Gold Inflection

Identified major inflections at Rochester expansion prior to the precious metals breakout, with massive operating leverage kicking in as silver broke above $30/oz.

Initial Thesis$4.85
Peak / Target$12.80+
StatusTarget Met
NYSE: CGAU +122% Gain

Centerra Gold Inc.

Low-Cost Gold Compounder

Mount Milligan mine life extension coupled with pristine zero-debt balance sheet and aggressive share repurchases during the Stage 1 basing transition.

Initial Thesis$6.20
Peak / Target$13.80
StatusActive Winner
NYSE: PLTR +180% Gain

Palantir Technologies

Enterprise AIP & Sovereign Moat

Flagged commercial bootcamps driving unprecedented enterprise adoption velocity, GAAP profitability inflection, and institutional S&P 500 re-weighting.

Initial Thesis$21.40
Peak / Target$60.00+
StatusCompounding
NASDAQ: AVGO +115% Gain

Broadcom Inc.

Custom Hyperscaler XPUs & Networking

Recognized AVGO as the indispensable ASIC partner for Google TPU v7 and Meta MTIA, paired with rapid subscription revenue conversions at VMware.

Initial Thesis$140.00
Peak / Target$300.00+
StatusCompounding
NYSE: BSX +58% Gain

Boston Scientific Corp.

Electrophysiology Supercycle

Identified FARAPULSE Pulsed Field Ablation (PFA) as a generational disruptive standard of care capturing overwhelming market share in atrial fibrillation treatment.

Initial Thesis$68.00
Peak / Target$108.00
StatusTarget Met
NASDAQ: HOOD +195% Peak

Robinhood Markets Inc.

Retail Capital Rotation & Operating Leverage

Surfaced operating leverage expanding faster than consensus estimates with crypto monetization, institutional custody, and Bitstamp acquisition.

Initial Thesis$13.80
Peak / Target$40.00+
StatusTarget Met

The Anatomy of a Muffett Best Call

Every idea we publish must satisfy three strict filters: (1) an undeniable secular megatrend, (2) asymmetric upside with a durable margin of safety, and (3) Stage 2 technical confirmation backed by institutional volume. We never chase momentum without fundamental valuation support.

Explore Full Equity Research